IBD (n = 24) | Non-IBD Controls (n = 20) | Pvalue† | |
---|---|---|---|
Age (mean +/− range) | 45 (19–90) | 56 (22–88) | 0.045 |
Female:Male | 7:17 | 11:9 | 0.153‡ |
Co-morbid illnesses, n (%) | |||
Type 2 diabetes mellitus | 2 | 3 | |
Chronic kidney disease | 1 | 0 | |
Atrial fibrillation | 1 | 0 | |
Ischaemic heart disease | 1 | 2 | |
Colorectal adenocarcinoma | 0 | 1 | |
Other cancer | 1 | 3 | |
Body mass index (mean +/− range) | 26.9 (17.6–51.3) | 26.5 (5.43) | 0.866 |
Haemoglobin (g/L, mean, range) | 121 (62–153) | 124 (86–162) | 0.597 |
MCV (10−15L, mean, range) | 82 (55–96) | 81 (68–88) | 0.601 |
Serum ferritin (ng/mL, mean, range) | 30 (3–93) | 25 (7–62) | 0.395 |
White cell count (× 109/L, mean, range) | 7.6 (4.0–10.9) | 6.8 (3.7–21.4) | 0.416 |
Platelet count (× 109/L, mean, range) | 318 (150–680) | 237 (143–366) | 0.009 |
eGFR (mL/min/1.73m2, mean, range) | 85 (38 - > 90) | 80 (45- > 90) | 0.273 |
Serum albumin (g/L, mean, range) | 35 (25–48) | 38 (30–50) | 0.064 |
Serum C-reactive protein (mg/L, median, range) | 3 (< 2–18) | < 2 (< 2–15) | 0.228 |
Faecal calprotectin (μg/g, median, range) | 573 (< 15- > 3000) | 47 (< 15–300) | 0.023 |
25(OH) vitamin D (nmol/L, mean, range) | 51 (8–104) | 49 (20–96) | 0.822 |
1,25(di-OH) vitamin D (pmol/L, mean, range) | 112 (50–202) | 136 (62–263) | 0.109 |
Serum calcium (corrected, mmol/L, mean ± 95% CI) | 2.40 (2.29–2.49) | 2.36 (2.21–2.55) | 0.115 |
Serum phosphate (mmol/L, mean ± 95% CI) | 1.11 (0.69–1.39) | 1.09 (0.63–1.60) | 0.700 |
Serum parathyroid hormone (pmol/L, mean ± 95% CI) | 5.1 (1.9–12.1) | 6.3 (1.4–11.5) | 0.103 |